Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Option Care Health (OPCH) Cost of Revenue: 2009-2025

Historic Cost of Revenue for Option Care Health (OPCH) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.

  • Option Care Health's Cost of Revenue rose 1373.24% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 billion, marking a year-over-year increase of 1777.48%. This contributed to the annual value of $4.0 billion for FY2024, which is 1999.66% up from last year.
  • Per Option Care Health's latest filing, its Cost of Revenue stood at $1.2 billion for Q3 2025, which was up 1373.24% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Option Care Health's Cost of Revenue registered a high of $1.2 billion during Q3 2025, and its lowest value of $593.8 million during Q1 2021.
  • Its 5-year average for Cost of Revenue is $864.3 million, with a median of $818.2 million in 2023.
  • Its Cost of Revenue has fluctuated over the past 5 years, first skyrocketed by 446.26% in 2023, then soared by 2288.61% in 2024.
  • Quarter analysis of 5 years shows Option Care Health's Cost of Revenue stood at $715.0 million in 2021, then rose by 11.35% to $796.1 million in 2022, then rose by 10.19% to $877.3 million in 2023, then increased by 22.89% to $1.1 billion in 2024, then grew by 7.8% to $1.2 billion in 2025.
  • Its Cost of Revenue stands at $1.2 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.1 billion for Q1 2025.